Skip to main content

Advertisement

SpringerLink
Log in

30-day mortality in UK patients with bacteraemic community-acquired pneumonia

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Objectives

To determine 7 and 30-day mortality in consecutive patients with bacteraemic community-acquired pneumonia (CAP) and the association between predicted variables and likelihood of death.

Methods

From August 2007 to July 2011, demographic, clinical and microbiological data were prospectively collected on patients with bacteraemic CAP. Patients were followed until death, hospital discharge or recovery from infection. Univariate and multivariate analysis was performed to determine the association between predictor variables and 30-day mortality.

Results

7-day mortality was 61/252 [24.4 %, 95 % confidence interval (CI) 19.1–30.0 %] and by 30 days, this had risen to 77/252 (30.6 %, 95 % CI 24.9–36.6 %). In univariate analysis, factors associated with 30-day mortality were age, speciality within 48 h of admission, blood culture isolate and Charlson co-morbidity index (CCI). In multivariate analysis, age and CCI remained significantly associated. There was also a trend towards significance for meticillin-sensitive Staphylococcus aureus (MSSA) and Pseudomonas aeruginosa blood culture isolates compared to Streptococcus pneumoniae.

Conclusions

Overall, bacteraemic CAP was associated with high inpatient mortality. Because of their association with poor outcomes, patients with MSSA and P. aeruginosa bacteraemic CAP require further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Capelastegui A, España PP, Bilbao A, Gamazo J, Medel F, Salgado J, et al. Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care. J Infect. 2010;61:364–71.

    Article  PubMed  Google Scholar 

  2. Chetty K, Thomson AH. Management of community-acquired pneumonia in children. Paediatr Drugs. 2007;9:401–11.

    Article  PubMed  Google Scholar 

  3. Woodhead MA, MacFarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987;1:671–4.

    Article  PubMed  CAS  Google Scholar 

  4. British Thoracic Society. Community-acquired pneumonia in adults in British Hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med. 1987;62:195–220.

    Google Scholar 

  5. White RJ, Blainey AD, Harrison KJ, Clarke SK. Causes of pneumonia presenting to a district general hospital. Thorax. 1981;36:566–70.

    Article  PubMed  CAS  Google Scholar 

  6. MacFarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet. 1982;2:255–8.

    Article  PubMed  CAS  Google Scholar 

  7. Mongardon N, Max A, Bouglé A, Pène F, Lemiale V, Charpentier J, et al. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care. 2012;16:R155.

    Article  PubMed  Google Scholar 

  8. Müllerova H, Chigbo C, Hagan GW, Woodhead MA, Miravitlles M, Davis KJ, et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Resp Med. 2012;106:1124–33.

    Article  Google Scholar 

  9. Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340–6.

    Article  PubMed  Google Scholar 

  10. Challen K, Bentley A, Walter D. Severity of illness assessment in community-acquired pneumonia. Thorax. 2011;66:351.

    Article  PubMed  Google Scholar 

  11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30:536–55.

    Article  PubMed  Google Scholar 

  12. Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect. 2011;139:1307–16.

    Article  PubMed  Google Scholar 

  13. Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, et al. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. J Infect. 2013;66:34–40.

    Article  PubMed  Google Scholar 

  14. Ruiz LA, Gómez A, Jaca C, Martínez L, Gómez B, Zalacain R. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection. 2010;38:453–8.

    Article  PubMed  CAS  Google Scholar 

  15. Sarkar TK, Murarka RS, Gilardi GL. Primary Streptococcus viridans pneumonia. Chest. 1989;96:831–4.

    Article  PubMed  CAS  Google Scholar 

  16. Park SY, Park HJ, Moon SM, Park KH, Chong YP, Kim MN, et al. Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia. BMC Infect Dis. 2012;12:308.

    Article  PubMed  Google Scholar 

  17. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29:1171–7.

    Article  PubMed  Google Scholar 

  18. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med. 2001;95:78–82.

    Article  PubMed  CAS  Google Scholar 

  19. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64:iii1–55.

    Article  PubMed  Google Scholar 

  20. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45:329–37.

    Article  PubMed  Google Scholar 

  21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  PubMed  CAS  Google Scholar 

  22. Andrews JM; BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother. 2007;60:20–41.

    Article  PubMed  CAS  Google Scholar 

  23. Kunimasa K, Ishida T, Kimura S, Tanaka M, Kouyama Y, Yamashita S, et al. Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man. Intern Med. 2012;51:2473–8.

    Article  PubMed  Google Scholar 

  24. Chuang TY, Lin CJ, Lee SW, Chuang CP, Jong YS, Chen WJ, et al. Rapidly fatal community-acquired pneumonia due to Klebsiella pneumoniae complicated with acute myocarditis and accelerated idioventricular rhythm. J Microbiol Immunol Infect. 2012;45:321–3.

    Article  PubMed  Google Scholar 

  25. Kwong JC, Chua K, Charles PG. Managing severe community-acquired pneumonia due to community methicillin-resistant Staphylococcus aureus (MRSA). Curr Infect Dis Rep. 2012;14:330–8.

    Article  PubMed  Google Scholar 

  26. Karampela I, Poulakou G, Dimopoulos G. Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol. 2012;78:930–40.

    PubMed  CAS  Google Scholar 

  27. Nimmo GR. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2012;18:725–34.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

I would like to thank my colleagues Dr. Sandra Lacey, Dr. Simon Namnyak, Dr. Lindsey Bain and Dr. Meredydd Nicholas who helped to collect these data.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Infection, Barts Health NHS Trust, 3rd Floor Pathology and Pharmacy Building, 80 Newark Street, London, E1 2ES, UK

    M. Melzer

  2. Department of Primary Care and Population Health, University College London, Rowland Hill Street, London, NW3 2PF, UK

    C. Welch

Authors
  1. M. Melzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Welch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Melzer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melzer, M., Welch, C. 30-day mortality in UK patients with bacteraemic community-acquired pneumonia. Infection 41, 1005–1011 (2013). https://doi.org/10.1007/s15010-013-0462-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0462-7

Keywords

Search

Navigation